Jiro Uehara

1.6k total citations
29 papers, 488 citations indexed

About

Jiro Uehara is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Jiro Uehara has authored 29 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Dermatology and 10 papers in Molecular Biology. Recurrent topics in Jiro Uehara's work include Cancer and Skin Lesions (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (7 papers). Jiro Uehara is often cited by papers focused on Cancer and Skin Lesions (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and CAR-T cell therapy research (7 papers). Jiro Uehara collaborates with scholars based in Japan, United States and Germany. Jiro Uehara's co-authors include Naoya Yamazaki, Hisashi Uhara, Tatsuya Takenouchi, Yasuhiro Fujisawa, Hiroshi Uchi, Hironobu Minami, Yoshio Kiyohara, Hajime Iizuka, Hironobu Ihn and Yasuhiro Ito and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Journal of the American Academy of Dermatology.

In The Last Decade

Jiro Uehara

28 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Uehara Japan 12 382 186 137 110 90 29 488
Florian Schenck Germany 8 244 0.6× 96 0.5× 95 0.7× 98 0.9× 48 0.5× 12 325
Danielle M. Bello United States 12 401 1.0× 145 0.8× 110 0.8× 74 0.7× 118 1.3× 23 451
Erica B. Friedman United States 10 221 0.6× 209 1.1× 89 0.6× 36 0.3× 49 0.5× 27 450
John W Kelly Australia 11 208 0.5× 112 0.6× 32 0.2× 70 0.6× 78 0.9× 23 327
Burkhard Bueltmann Germany 6 252 0.7× 121 0.7× 74 0.5× 47 0.4× 90 1.0× 10 318
Ha Linh Vu United States 9 140 0.4× 152 0.8× 46 0.3× 118 1.1× 31 0.3× 10 499
Benjamin Benhuri United States 5 273 0.7× 71 0.4× 66 0.5× 48 0.4× 27 0.3× 8 355
Anne Zaremba Germany 10 201 0.5× 113 0.6× 107 0.8× 16 0.1× 24 0.3× 28 317
Daniela Göppner Germany 10 103 0.3× 85 0.5× 36 0.3× 47 0.4× 54 0.6× 16 248
Bożena Cybulska-Stopa Poland 11 246 0.6× 102 0.5× 81 0.6× 16 0.1× 36 0.4× 58 330

Countries citing papers authored by Jiro Uehara

Since Specialization
Citations

This map shows the geographic impact of Jiro Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Uehara more than expected).

Fields of papers citing papers by Jiro Uehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Uehara. The network helps show where Jiro Uehara may publish in the future.

Co-authorship network of co-authors of Jiro Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Uehara. A scholar is included among the top collaborators of Jiro Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Uehara. Jiro Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoashi, Toshihiko, Masashi Ishikawa, Jiro Uehara, et al.. (2024). Japanese Dermatological Association guidelines: Outlines of Japanese clinical guidelines for basal cell carcinoma 2021. The Journal of Dermatology. 51(4). e90–e105. 3 indexed citations
2.
Fujisawa, Yasuhiro, Takamichi Ito, Hiroshi Kato, et al.. (2021). Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases. European Journal of Cancer. 145. 210–220. 33 indexed citations
3.
Maeda, Takuya, et al.. (2021). Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia. European Journal of Dermatology. 31(5). 662–664. 1 indexed citations
4.
Goto, Keisuke, Yoji Kukita, Keiichiro Honma, et al.. (2021). Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis. Modern Pathology. 35(1). 33–43. 13 indexed citations
5.
Maeda, Takuya, et al.. (2021). Neutrophil-to-lymphocyte ratio is associated with survival and sentinel lymph node positivity in invasive cutaneous squamous cell carcinoma: A retrospective study. Journal of the American Academy of Dermatology. 86(3). 615–620. 11 indexed citations
6.
Matsuya, Taisuke, Yasuhiro Nakamura, Shigeto Matsushita, et al.. (2020). Vitiligo expansion and extent correlate with durable response in anti‐programmed death 1 antibody treatment for advanced melanoma: A multi‐institutional retrospective study. The Journal of Dermatology. 47(6). 629–635. 20 indexed citations
7.
Morizane, Shin, Toshihisa Hamada, Tomoko Miyake, et al.. (2019). The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T‐cell lymphoma. The Journal of Dermatology. 46(11). 967–977. 8 indexed citations
8.
Yamazaki, Naoya, Yoshio Kiyohara, Hisashi Uhara, et al.. (2019). Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma. Cancer Science. 110(6). 1995–2003. 28 indexed citations
9.
Yoshino, Koji, Takuya Maeda, Kojiro Nagai, et al.. (2019). Continued Chemotherapy After Concurrent Chemoradiotherapy Improves Treatment Outcomes for Unresectable Cutaneous Squamous Cell Carcinoma: An Analysis of 13 Cases. Frontiers in Medicine. 6. 207–207. 2 indexed citations
10.
Maeda, Takuya, Koji Yoshino, Kojiro Nagai, et al.. (2019). Dynamics of neutrophil and C‐reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib. The Journal of Dermatology. 46(8). 716–719. 3 indexed citations
11.
Fukudo, Masahide, Norihisa Kimura, Takaaki Sasaki, et al.. (2019). Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti–PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice.. Journal of Clinical Oncology. 37(15_suppl). 3120–3120. 1 indexed citations
12.
Uehara, Jiro, Takayuki Ohkuri, Akemi Kosaka, et al.. (2017). Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. Biochemical and Biophysical Research Communications. 490(2). 521–527. 21 indexed citations
13.
Yamazaki, Naoya, Yoshio Kiyohara, Hisashi Uhara, et al.. (2017). Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma. Cancer Science. 108(5). 1022–1031. 96 indexed citations
14.
Tsutsumida, Arata, Akira Takahashi, Kenjiro Namikawa, et al.. (2016). Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan. International Journal of Clinical Oncology. 21(4). 796–800. 5 indexed citations
15.
Sasajima, Junpei, Jiro Uehara, Takuma Goto, et al.. (2016). Pancreatic metastasis of angiosarcoma (Stewart–Treves syndrome) diagnosed using endoscopic ultrasound-guided fine needle aspiration. Medicine. 95(33). e4316–e4316. 6 indexed citations
16.
Sakaizawa, Kaori, Atsuko Ashida, Aya Uchiyama, et al.. (2015). Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. Journal of Dermatological Science. 80(1). 33–37. 83 indexed citations
17.
Ito, Yasuhiro, et al.. (2012). Prognostic Indicators in 35 Patients with Extramammary Paget's Disease. Dermatologic Surgery. 38(12). 1938–1944. 49 indexed citations
18.
Fujii, Mizue, Jiro Uehara, Masaru Honma, et al.. (2010). Primary cutaneous γδ‐T‐cell lymphoma treated with low‐dose methotrexate and narrowband ultraviolet B irradiation: Report of a case with testicular involvement. The Journal of Dermatology. 38(4). 368–372. 11 indexed citations
19.
Uehara, Jiro, Yasuhiro Ito, Ichiro Takahashi, et al.. (2010). Sequential Acral Lentiginous Melanomas of the Foot. Case Reports in Dermatology. 2(3). 201–206. 2 indexed citations
20.
Uehara, Jiro, et al.. (1995). [Pathway of the radial artery located with a small-caliber Doppler probe for arterial cannulation in pediatric patients].. PubMed. 44(3). 414–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Schenck Breakdown of academic impact, for papers by Danielle M. Bello Breakdown of academic impact, for papers by Erica B. Friedman Breakdown of academic impact, for papers by John W Kelly Breakdown of academic impact, for papers by Burkhard Bueltmann Breakdown of academic impact, for papers by Ha Linh Vu Breakdown of academic impact, for papers by Benjamin Benhuri Breakdown of academic impact, for papers by Anne Zaremba Breakdown of academic impact, for papers by Daniela Göppner Breakdown of academic impact, for papers by Bożena Cybulska-Stopa
Rankless by CCL
2026